Evidence map›Paper›PMID 30479274›Full record

ArticleeLife2018

Selective agonist of TRPML2 reveals direct role in chemokine release from innate immune cells.

Eva Plesch, Cheng-Chang Chen, Elisabeth Butz, Anna Scotto Rosato, Einar K Krogsaeter, Hua Yinan, Karin Bartel, Marco Keller, Dina Robaa, Daniel Teupser and 9 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 101 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. The ion channels of endomembranes.Physiological reviews · 2024
    Review
  17. Article
  18. Review
  19. Molecular and structural basis of the dual regulation of the polycystin-2 ion channel by small-molecule ligands.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 3 countries.

Eva Plesch *Department of Pharmacy, Center for Drug Research and Center for Integrated Protein Science Munich, Ludwig Maximilian University of Munich, Munich, Germany.
Cheng-Chang Chen *Department of Pharmacy, Center for Drug Research and Center for Integrated Protein Science Munich, Ludwig Maximilian University of Munich, Munich, Germany.
Elisabeth Butz *Department of Pharmacy, Center for Drug Research and Center for Integrated Protein Science Munich, Ludwig Maximilian University of Munich, Munich, Germany.ORCID 0000-0002-5956-6434
Anna Scotto RosatoTelethon Institute of Genetics and Medicine, Naples, Italy.
Einar K KrogsaeterDepartment of Pharmacology and Toxicology, Medical Faculty, Ludwig Maximilian University of Munich, Munich, Germany.ORCID 0000-0001-8232-5498
Hua YinanCell Biology and Physiology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, United States.
Karin BartelDepartment of Pharmacy, Center for Drug Research and Center for Integrated Protein Science Munich, Ludwig Maximilian University of Munich, Munich, Germany.
Marco KellerDepartment of Pharmacy, Center for Drug Research and Center for Integrated Protein Science Munich, Ludwig Maximilian University of Munich, Munich, Germany.
Dina RobaaDepartment of Pharmaceutical Chemistry, Institute of Pharmacy, Martin Luther University of Halle-Wittenberg, Halle, Germany.
Daniel TeupserInstitute of Laboratory Medicine, University Hospital Munich, Munich, Germany.
Lesca M HoldtInstitute of Laboratory Medicine, University Hospital Munich, Munich, Germany.
Angelika M VollmarDepartment of Pharmacy, Center for Drug Research and Center for Integrated Protein Science Munich, Ludwig Maximilian University of Munich, Munich, Germany.
Wolfgang SipplDepartment of Pharmaceutical Chemistry, Institute of Pharmacy, Martin Luther University of Halle-Wittenberg, Halle, Germany.
Rosa PuertollanoCell Biology and Physiology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, United States.ORCID 0000-0002-1106-5489
Diego MedinaTelethon Institute of Genetics and Medicine, Naples, Italy.
Martin BielDepartment of Pharmacy, Center for Drug Research and Center for Integrated Protein Science Munich, Ludwig Maximilian University of Munich, Munich, Germany.
Christian Wahl-SchottInstitute for Neurophysiology, Hannover Medical School, Hannover, Germany.
Franz BracherDepartment of Pharmacy, Center for Drug Research and Center for Integrated Protein Science Munich, Ludwig Maximilian University of Munich, Munich, Germany.
Christian GrimmDepartment of Pharmacology and Toxicology, Medical Faculty, Ludwig Maximilian University of Munich, Munich, Germany.ORCID 0000-0002-0177-5559
Center for Integrated Protein Science Munich · DELudwig-Maximilians-Universität München · DEMartin Luther University Halle-Wittenberg · DEMünchen Klinik · DENational Institutes of Health · USTelethon Institute Of Genetics And Medicine · ITMedizinische Hochschule Hannover · DE

Funding

Role of endolysosomal channels in calcium homeostasis and traffickingZIAHL006075 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI PUERTOLLANO, ROSA · 2010 to 2025
$8.7M
6 · The paper itself

Abstract

Cytokines and chemokines are produced and secreted by a broad range of immune cells including macrophages. Remarkably, little is known about how these inflammatory mediators are released from the various immune cells. Here, the endolysosomal cation channel TRPML2 is shown to play a direct role in chemokine trafficking and secretion from murine macrophages. To demonstrate acute and direct involvement of TRPML2 in these processes, the first isoform-selective TRPML2 channel agonist was generated, ML2-SA1. ML2-SA1 was not only found to directly stimulate release of the chemokine CCL2 from macrophages but also to stimulate macrophage migration, thus mimicking CCL2 function. Endogenous TRPML2 is expressed in early/recycling endosomes as demonstrated by endolysosomal patch-clamp experimentation and ML2-SA1 promotes trafficking through early/recycling endosomes, suggesting CCL2 being transported and secreted via this pathway. These data provide a direct link between TRPML2 activation, CCL2 release and stimulation of macrophage migration in the innate immune response.

Indexed as

AnimalsCell MovementChemokine CCL2Immunologic FactorsMacrophagesMice, Inbred C57BLTransient Receptor Potential ChannelsCcl2 protein, mouseChemokine CCL2Immunologic FactorsMcoln2 protein, mouseTransient Receptor Potential ChannelsbiochemistryCCL2chemical biologylysosomemacrophageMcoln2mouseTRPMLTRPML2

Identifiers

PMID30479274
PMCPMC6257821
OpenAlexW2900632225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.